This inventor holds 1 USPTO granted patent. Top assignees: Medstar Health, Oxford University Innovation Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024
Title: The Innovative Contributions of Adrian P Banning
Introduction
Adrian P Banning is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical technology, particularly in the assessment of microvascular dysfunction. His innovative approach has the potential to enhance patient care and improve diagnostic accuracy.
Latest Patents
Banning holds a patent for a groundbreaking invention titled "Noninvasive assessment of microvascular dysfunction." This patent outlines systems and methods for assessing microvascular dysfunction in patients. The process involves acquiring a series of images from a specific region of interest within the patient's body. From these images, an imaging-derived index of microcirculatory resistance is determined. A clinical parameter representing microvascular dysfunction is then assigned to the patient through a predictive model based on the imaging-derived index.
Career Highlights
Throughout his career, Adrian P Banning has worked with esteemed organizations such as Medstar Health and Oxford University Innovation Limited. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical diagnostics.
Collaborations
Banning has collaborated with notable professionals in his field, including Hector Manuel Garcia Garcia and Giovanni Luigi De Maria. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Adrian P Banning's contributions to the field of medical technology through his patent on noninvasive assessment of microvascular dysfunction exemplify the importance of innovation in healthcare. His work not only showcases his expertise but also highlights the potential for improved patient outcomes through advanced diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile